These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27717916)

  • 1. Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment.
    Abdelbary AA; Abd-Elsalam WH; Al-Mahallawi AM
    Int J Pharm; 2016 Nov; 513(1-2):688-696. PubMed ID: 27717916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of Highly Deformable Bilosomes for Enhancing the Topical Delivery of Terconazole: In Vitro Characterization, Microbiological Evaluation, and In Vivo Skin Deposition Study.
    Mosallam S; Sheta NM; Elshafeey AH; Abdelbary AA
    AAPS PharmSciTech; 2021 Feb; 22(2):74. PubMed ID: 33586022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and in vivo assessment of terconazole-loaded polymeric mixed micelles enriched with Cremophor EL as dual functioning mediator for augmenting physical stability and skin delivery.
    Abd-Elsalam WH; El-Zahaby SA; Al-Mahallawi AM
    Drug Deliv; 2018 Nov; 25(1):484-492. PubMed ID: 29411650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.
    Al-Mahallawi AM; Abdelbary AA; Aburahma MH
    Int J Pharm; 2015 May; 485(1-2):329-40. PubMed ID: 25796122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated nanovesicular/self-nanoemulsifying system (INV/SNES) for enhanced dual ocular drug delivery: statistical optimization, in vitro and in vivo evaluation.
    Yousry C; Zikry PM; Salem HM; Basalious EB; El-Gazayerly ON
    Drug Deliv Transl Res; 2020 Jun; 10(3):801-814. PubMed ID: 31989414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gel in core carbosomes as novel ophthalmic vehicles with enhanced corneal permeation and residence.
    Moustafa MA; El-Refaie WM; Elnaggar YSR; Abdallah OY
    Int J Pharm; 2018 Jul; 546(1-2):166-175. PubMed ID: 29778824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment.
    Albash R; El-Nabarawi MA; Refai H; Abdelbary AA
    Int J Nanomedicine; 2019; 14():6555-6574. PubMed ID: 31616143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing Spanlastics for Improving the Ocular Delivery of Clotrimazole: In vitro Characterization, Ex vivo Permeability, Microbiological Assessment and In vivo Safety Study.
    Abdelbari MA; El-Mancy SS; Elshafeey AH; Abdelbary AA
    Int J Nanomedicine; 2021; 16():6249-6261. PubMed ID: 34531656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation.
    Mosallam S; Ragaie MH; Moftah NH; Elshafeey AH; Abdelbary AA
    Int J Nanomedicine; 2021; 16():119-132. PubMed ID: 33447031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brij® integrated bilosomes for improving the transdermal delivery of niflumic acid for effective treatment of osteoarthritis: In vitro characterization, ex vivo permeability assessment, and in vivo study.
    Abdelbari MA; El-Gazar AA; Abdelbary AA; Elshafeey AH; Mosallam S
    Int J Pharm; 2023 Jun; 640():123024. PubMed ID: 37156309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced non invasive trans-tympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: Fabrication, in-vitro characterization, and comparative ex-vivo permeation studies.
    Al-Mahallawi AM; Khowessah OM; Shoukri RA
    Int J Pharm; 2017 Apr; 522(1-2):157-164. PubMed ID: 28279741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole.
    Kaur IP; Rana C; Singh M; Bhushan S; Singh H; Kakkar S
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):484-96. PubMed ID: 22694593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: in vitro characterization, ex vivo permeation and in vivo skin deposition study.
    Aziz DE; Abdelbary AA; Elassasy AI
    J Liposome Res; 2019 Mar; 29(1):73-85. PubMed ID: 29355060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Penetration Ability of Carbonic Anhydrase Inhibitor-Loaded Ultradeformable Bilosome for Effective Ocular Application.
    Nair VS; Srivastava V; Bhavana V; Yadav R; Rajana N; Singh SB; Mehra NK
    AAPS PharmSciTech; 2023 Jul; 24(6):157. PubMed ID: 37470885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect.
    Moustafa MA; Elnaggar YSR; El-Refaie WM; Abdallah OY
    Int J Pharm; 2017 Dec; 534(1-2):14-24. PubMed ID: 28987453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.
    Abdelbary GA; Amin MM; Zakaria MY
    Drug Deliv; 2017 Nov; 24(1):309-319. PubMed ID: 28165809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle.
    ElMeshad AN; Mohsen AM
    Drug Deliv; 2016 Sep; 23(7):2115-2123. PubMed ID: 25080226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-enriched bilosomes: an approach to enhance ocular delivery of agomelatine via D-optimal design: formulation,
    Nemr AA; El-Mahrouk GM; Badie HA
    Drug Deliv; 2022 Dec; 29(1):2343-2356. PubMed ID: 35869684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micelle carriers based on macrogol 15 hydroxystearate for ocular delivery of terbinafine hydrochloride: In vitro characterization and in vivo permeation.
    Zhou T; Zhu L; Xia H; He J; Liu S; He S; Wang L; Zhang J
    Eur J Pharm Sci; 2017 Nov; 109():288-296. PubMed ID: 28823856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
    Elsherif NI; Shamma RN; Abdelbary G
    AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.